Reuters logo
BRIEF-Astrazeneca divests rights to Rhinocort Aqua outside US
October 7, 2016 / 6:05 AM / a year ago

BRIEF-Astrazeneca divests rights to Rhinocort Aqua outside US

Oct 7 (Reuters) - Astrazeneca Plc

* Enters agreement with Cilag GMBH International to divest rights to Rhinocort Aqua outside US

* $330 million payment received from Cilag gmbh international upon completion of transaction will be recognised as other operating income

* Transaction does not include transfer of any Astrazeneca employees or facilities and does not impact company’s financial guidance

* AZ divests rights to Rhinocort Aqua outside US

* Agreement is subject to customary closing conditions and is expected to complete in Q4 of 2016 Source text for Eikon: Further company coverage: (London newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below